Genome mining, isolation, chemical synthesis and biological evaluation of a novel lanthipeptide, tikitericin, from the extremophilic microorganism Thermogemmatispora strain T81† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c8sc02170h
暂无分享,去创建一个
E. J. Aitken | Robert A Keyzers | M. Brimble | M. Stott | J. F. Power | P. Harris | Margaret A Brimble | Buzhe Xu | Emma J Aitken | Benjamin P Baker | Claire A Turner | Joanne E Harvey | Matthew B Stott | Jean F Power | Paul W R Harris | J. Harvey | R. Keyzers | Buzhe Xu | C. Turner | Benjamin P. Baker
[1] Hon Wai Leong,et al. Tutorial on de novo peptide sequencing using MS/MS Mass spectrometry , 2012, J. Bioinform. Comput. Biol..
[2] M. Dawson,et al. New horizons for host defense peptides and lantibiotics. , 2012, Current opinion in pharmacology.
[3] O. Kuipers,et al. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. , 1999, Science.
[4] J. Vederas,et al. Synthesis and biological activity of oxa-lacticin A2, a lantibiotic analogue with sulfur replaced by oxygen. , 2009, Organic letters.
[5] A. Tabor. Recent advances in synthetic analogues of lantibiotics: What can we learn from these? , 2014, Bioorganic chemistry.
[6] Matthew R. Levengood,et al. In Vitro Mutasynthesis of Lantibiotic Analogues Containing Nonproteinogenic Amino Acids , 2009, Journal of the American Chemical Society.
[7] O. Kuipers,et al. Dissection and Modulation of the Four Distinct Activities of Nisin by Mutagenesis of Rings A and B and by C-Terminal Truncation , 2007, Applied and Environmental Microbiology.
[8] D. Craik,et al. α-Conotoxin ImI incorporating stable cystathionine bridges maintains full potency and identical three-dimensional structure. , 2011, Journal of the American Chemical Society.
[9] W. A. van der Donk,et al. Chemical Synthesis and Biological Activity of Analogues of the Lantibiotic Epilancin 15X , 2012, Journal of the American Chemical Society.
[10] J. Vederas,et al. The synthesis of active and stable diaminopimelate analogues of the lantibiotic peptide lactocin S. , 2012, Journal of the American Chemical Society.
[11] J. Vederas,et al. Solid supported chemical syntheses of both components of the lantibiotic lacticin 3147. , 2011, Journal of the American Chemical Society.
[12] Judit Tulla-Puche,et al. ChemMatrix, a poly(ethylene glycol)-based support for the solid-phase synthesis of complex peptides. , 2006, Journal of combinatorial chemistry.
[13] J. Vederas,et al. Synthesis of the lantibiotic lactocin S using peptide cyclizations on solid phase. , 2010, Journal of the American Chemical Society.
[14] Erin E. Carlson,et al. Collision-Induced Dissociation Mass Spectrometry: A Powerful Tool for Natural Product Structure Elucidation. , 2015, Analytical chemistry.
[15] P. Driscoll,et al. Synthesis of orthogonally protected lanthionines. , 2003, The Journal of organic chemistry.
[16] G. LaPointe,et al. MICs of Mutacin B-Ny266, Nisin A, Vancomycin, and Oxacillin against Bacterial Pathogens , 2000, Antimicrobial Agents and Chemotherapy.
[17] R. P. Ross,et al. Bacterial lantibiotics: strategies to improve therapeutic potential. , 2005, Current protein & peptide science.
[18] M. Alam,et al. Isolation of novel bacteria, including a candidate division, from geothermal soils in New Zealand. , 2008, Environmental microbiology.
[19] J. Vederas,et al. Multiple on-resin olefin metathesis to form ring-expanded analogues of the lantibiotic peptide, lacticin 3147 A2. , 2007, Organic letters.
[20] J. Vederas,et al. Fundamental functionality: recent developments in understanding the structure–activity relationships of lantibiotic peptides , 2011, The Journal of Antibiotics.
[21] R. Liskamp,et al. Synthesis of Bicyclic Alkene‐/Alkane‐Bridged Nisin Mimics by Ring‐Closing Metathesis and their Biochemical Evaluation as Lipid II Binders: toward the Design of Potential Novel Antibiotics , 2007, Chembiochem : a European journal of chemical biology.
[22] J. Vederas,et al. Solid-supported synthesis and biological evaluation of the lantibiotic peptide bis(desmethyl) lacticin 3147 A2. , 2008, Angewandte Chemie.
[23] C. Hill,et al. The dawning of a ‘Golden era’ in lantibiotic bioengineering , 2010, Molecular microbiology.
[24] A. Tabor. The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides. , 2011, Organic & biomolecular chemistry.
[25] Weixin Tang,et al. The Sequence of the Enterococcal Cytolysin Imparts Unusual Lanthionine Stereochemistry , 2013, Nature chemical biology.
[26] J. Willey,et al. Lantibiotics: peptides of diverse structure and function. , 2007, Annual review of microbiology.
[27] X. Yang,et al. Production of Lantipeptides in Escherichia coli , 2010, Journal of the American Chemical Society.
[28] M. Upton,et al. Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application , 2011, Expert opinion on drug discovery.
[29] H. Sahl,et al. Lantibiotics: mode of action, biosynthesis and bioengineering. , 2009, Current pharmaceutical biotechnology.
[30] G. Jung,et al. The tetracyclic lantibiotic actagardine. 1H-NMR and 13C-NMR assignments and revised primary structure. , 1995, European journal of biochemistry.
[31] E. Breukink,et al. Expanding role of lipid II as a target for lantibiotics. , 2007, Future microbiology.
[32] S. Mendo,et al. Congeneric lantibiotics from ribosomal in vivo peptide synthesis with noncanonical amino acids. , 2012, Angewandte Chemie.
[33] W. A. van der Donk,et al. Discovery, biosynthesis, and engineering of lantipeptides. , 2012, Annual review of biochemistry.
[34] Neha Garg,et al. Lantibiotics from Geobacillus thermodenitrificans , 2012, Proceedings of the National Academy of Sciences.
[35] A. Rickard,et al. Biomedical applications of nisin , 2016, Journal of applied microbiology.
[36] W. A. van der Donk,et al. Chemical Synthesis of the Lantibiotic Lacticin 481 Reveals the Importance of Lanthionine Stereochemistry , 2013, Journal of the American Chemical Society.
[37] John D Lambris,et al. Synthesis and activity of thioether-containing analogues of the complement inhibitor compstatin. , 2011, ACS chemical biology.
[38] K. Entian,et al. Entianin, a Novel Subtilin-Like Lantibiotic from Bacillus subtilis subsp. spizizenii DSM 15029T with High Antimicrobial Activity , 2011, Applied and Environmental Microbiology.
[39] S. Nair,et al. Mechanistic Understanding of Lanthipeptide Biosynthetic Enzymes , 2017, Chemical reviews.
[40] P. G. Arnison,et al. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. , 2013, Natural product reports.
[41] C. Hill,et al. Bioengineering Lantibiotics for Therapeutic Success , 2015, Front. Microbiol..
[42] W. A. van der Donk,et al. Synthesis and Bioactivity of Diastereomers of the Virulence Lanthipeptide Cytolysin. , 2016, Organic letters.
[43] P. Neubauer,et al. Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production , 2016, Microbial Cell Factories.
[44] Judit Tulla-Puche,et al. The synergy of ChemMatrix resin and pseudoproline building blocks renders RANTES, a complex aggregated chemokine. , 2006, Biopolymers.
[45] E. Breukink,et al. Lipid II as a target for antibiotics , 2006, Nature Reviews Drug Discovery.